Titan Biotech LimitedBSE: TITANBIO

Board Meeting Outcome for Outcome Of Board Meeting

· Issued by Titan Biotech Limited via BSE India

Filed with BSE ·

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors, at its meeting held today i.e. Friday 30th May, 2025, Approval of Audited Financial Results For The Fourth Quarter And Year Ended 31st March, 2025, Recommendation of Dividend, appointment of Secretarial Auditor, Appointment of Cost Auditor, Appointment of Internal Auditor,Appointment of Scrutinizer

View Attachment

6ix hasn’t read this filing yet.

View original source (BSE India)Titan Biotech Limited on 6ix

Earlier from Titan Biotech

Later from Titan Biotech

All Titan Biotech news releases